Bank of New York Mellon’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $19.1K | Hold |
|
|||||
|
2022
Q4 | $12.7K | Hold |
|
|||||
|
2022
Q3 | $23K | Hold |
|
|||||
|
2022
Q2 | $37K | Sell |
|
|||||
|
2022
Q1 | $285K | Sell |
|
|||||
|
2021
Q4 | $519K | Buy |
|
|||||
|
2021
Q3 | $913K | Sell |
|
|||||
|
2021
Q2 | $1.9M | Sell |
|
|||||
|
2021
Q1 | $2.76M | Sell |
|
|||||
|
2020
Q4 | $3.88M | Buy |
|
|||||
|
2020
Q3 | $1.58M | Buy |
|
|||||
|
2020
Q2 | $839K | Buy |
|
|||||
|
2020
Q1 | $321K | Hold |
|
|||||
|
2019
Q4 | $592K | Buy |
|
|||||
|
2019
Q3 | $437K | Buy |
|